DrugCite
Search

DUROTEP MT PATCH

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Durotep Mt Patch Adverse Events Reported to the FDA Over Time

How are Durotep Mt Patch adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Durotep Mt Patch, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Durotep Mt Patch is flagged as the suspect drug causing the adverse event.

Most Common Durotep Mt Patch Adverse Events Reported to the FDA

What are the most common Durotep Mt Patch adverse events reported to the FDA?

Wrong Technique In Drug Usage Proce...
105 (9.9%)
Drug Prescribing Error
56 (5.28%)
Delirium
32 (3.02%)
Nausea
32 (3.02%)
Somnolence
29 (2.73%)
Vomiting
29 (2.73%)
Overdose
28 (2.64%)
Constipation
24 (2.26%)
Pyrexia
24 (2.26%)
Altered State Of Consciousness
17 (1.6%)
Drug Administration Error
17 (1.6%)
Show More Show More
Respiratory Depression
17 (1.6%)
Myocardial Infarction
16 (1.51%)
Incorrect Dose Administered
15 (1.41%)
Malaise
15 (1.41%)
Death
14 (1.32%)
Dizziness
14 (1.32%)
Respiratory Failure
14 (1.32%)
Hepatic Failure
13 (1.23%)
Gastric Cancer
12 (1.13%)
Breast Cancer
11 (1.04%)
Depressed Level Of Consciousness
11 (1.04%)
Inappropriate Schedule Of Drug Admi...
11 (1.04%)
Pain
11 (1.04%)
Dysphagia
10 (.94%)
Myoclonus
10 (.94%)
Uterine Cancer
10 (.94%)
Malignant Neoplasm Progression
9 (.85%)
Neoplasm Malignant
9 (.85%)
Pancreatic Carcinoma
9 (.85%)
Aspiration
8 (.75%)
Blood Pressure Decreased
8 (.75%)
Lung Neoplasm Malignant
8 (.75%)
Oesophageal Carcinoma
8 (.75%)
Product Quality Issue
8 (.75%)
Respiratory Arrest
8 (.75%)
Treatment Noncompliance
8 (.75%)
Drug Effect Decreased
7 (.66%)
Feeling Abnormal
7 (.66%)
Ovarian Cancer
7 (.66%)
Restlessness
7 (.66%)
Anaemia
6 (.57%)
Cachexia
6 (.57%)
Delusion
6 (.57%)
Dementia
6 (.57%)
Drug Effect Increased
6 (.57%)
Drug Interaction
6 (.57%)
Eating Disorder
6 (.57%)
Hyperthermia
6 (.57%)
Prothrombin Time Prolonged
6 (.57%)
Pyelonephritis
6 (.57%)
Renal Failure
6 (.57%)
Sepsis
6 (.57%)
Stomatitis
6 (.57%)
Application Site Pruritus
5 (.47%)
Drug Ineffective
5 (.47%)
Inadequate Analgesia
5 (.47%)
Urine Output Decreased
5 (.47%)
Abdominal Discomfort
4 (.38%)
Abdominal Pain Lower
4 (.38%)
Abdominal Pain Upper
4 (.38%)
Aspartate Aminotransferase Increase...
4 (.38%)
Chest Discomfort
4 (.38%)
Convulsion
4 (.38%)
Depression
4 (.38%)
Discomfort
4 (.38%)
Disseminated Intravascular Coagulat...
4 (.38%)
Drug Administered At Inappropriate ...
4 (.38%)
Drug Exposure During Pregnancy
4 (.38%)
Dyspnoea
4 (.38%)
Eosinophil Count Increased
4 (.38%)
Fall
4 (.38%)
Haematemesis
4 (.38%)
Hallucination, Auditory
4 (.38%)
Hepatic Neoplasm Malignant
4 (.38%)
Hyperhidrosis
4 (.38%)
Hyperkalaemia
4 (.38%)
Hypotension
4 (.38%)
Ileus
4 (.38%)
Incontinence
4 (.38%)
Incorrect Route Of Drug Administrat...
4 (.38%)
Insomnia
4 (.38%)
Irritability
4 (.38%)
Lymphangiosis Carcinomatosa
4 (.38%)
Metastases To Bone
4 (.38%)
Metastases To Lung
4 (.38%)
Neutrophilia
4 (.38%)
Pollakiuria
4 (.38%)
Renal Impairment
4 (.38%)
Asphyxia
3 (.28%)
Bladder Cancer
3 (.28%)
Blood Albumin Decreased
3 (.28%)
Condition Aggravated
3 (.28%)
Drug Dispensing Error
3 (.28%)
Off Label Use
3 (.28%)
Withdrawal Syndrome
3 (.28%)
Abdominal Pain
2 (.19%)
Abnormal Behaviour
2 (.19%)
Aortic Aneurysm Rupture
2 (.19%)
Arrhythmia
2 (.19%)
Asthenia
2 (.19%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Durotep Mt Patch, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Durotep Mt Patch is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Durotep Mt Patch

What are the most common Durotep Mt Patch adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Durotep Mt Patch, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Durotep Mt Patch is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Durotep Mt Patch According to Those Reporting Adverse Events

Why are people taking Durotep Mt Patch, according to those reporting adverse events to the FDA?

Cancer Pain
144
Drug Use For Unknown Indication
69
Pain
18
Back Pain
10
Product Used For Unknown Indication
10
Scleroderma
9
Show More Show More
Arthralgia
6
Osteonecrosis
3
Large Intestine Carcinoma
3
Ill-defined Disorder
3
Malignant Ascites
2
Adenocarcinoma
2
Gastric Cancer
2
Pain Management
2
Lung Neoplasm Malignant
1
Peripheral Vascular Disorder
1
Procedural Pain
1
Metastatic Renal Cell Carcinoma
1
Rectal Cancer
1
Complex Regional Pain Syndrome
1
Bladder Cancer
1
Decubitus Ulcer
1

Durotep Mt Patch Case Reports

What Durotep Mt Patch safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Durotep Mt Patch. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Durotep Mt Patch.